Geneoscopy Revenue and Competitors

Location

$112.9M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Geneoscopy's estimated annual revenue is currently $12.2M per year.(i)
  • Geneoscopy's estimated revenue per employee is $155,000
  • Geneoscopy's total funding is $112.9M.

Employee Data

  • Geneoscopy has 79 Employees.(i)
  • Geneoscopy grew their employee count by 8% last year.

Geneoscopy's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
VP, Business Development and Biopharma PartneringReveal Email/Phone
3
VP SalesReveal Email/Phone
4
ControllerReveal Email/Phone
5
VP Software Engineering, Data Science and ITReveal Email/Phone
6
VP Product DevelopmentReveal Email/Phone
7
VP, Market Access and Revenue Cycle ManagementReveal Email/Phone
8
VP, Quality Assurance & Regulatory AffairsReveal Email/Phone
9
Head PeopleReveal Email/Phone
10
SVP Quality and RegulatoryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79.1M5106%N/AN/A
#2
$1.1M717%N/AN/A
#3
$4.2M27-32%N/AN/A
#4
$2M1330%N/AN/A
#5
$4.3M284%N/AN/A
#6
$0.9M60%N/AN/A
#7
$5M323%N/AN/A
#8
$3.7M244%N/AN/A
#9
$0.3M40%N/AN/A
#10
$6M3950%N/AN/A
Add Company

What Is Geneoscopy?

Geneoscopy is a life sciences company focused on the development of diagnostic tests for gastrointestinal health. Geneoscopy's lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded a Breakthrough Device Designated from the FDA for its ability to reduce morbidity associated with colorectal cancer through advanced adenoma detection. Preliminary trials suggest that the diagnostic can detect these lesions at a higher rate than all existing noninvasive screening tests.

keywords:N/A

$112.9M

Total Funding

79

Number of Employees

$12.2M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Geneoscopy News

2021-11-17 - Geneoscopy Closes $105M in Series B Funding

Geneoscopy, a ST Louis, MO-based life sciences company focused on development of diagnostic tests for gastrointestinal health, raised $105M in Series B funding. The round was led by Lightchain Capital and NT Investments with participation from Morningside Ventures, Labcorp, Cultivation Capital, ...

2021-03-17 - Geneoscopy Appoints Don Hardison to its Strategic Advisory Board

ST. LOUIS--(BUSINESS WIRE)--Mar 17, 2021-- Geneoscopy Inc., a life sciences company that develops diagnostic tests for gastrointestinal health, today announced the appointment of Don Hardison to the Company’s strategic advisory board. Don brings more than 40 years of executive leadership exper ...

2021-03-03 - Geneoscopy Appoints Vince Wong as Chief Commercial Officer

ST. LOUIS--(BUSINESS WIRE)--Mar 3, 2021-- Geneoscopy Inc., a life sciences company that develops diagnostic tests for gastrointestinal health, today announced the appointment of Vince Wong as Chief Commercial Officer. Mr. Wong brings almost 18 years of experience from Roche Diagnostics, where ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M79-8%N/A
#2
$75M79-7%N/A
#3
$9.5M79-5%N/A
#4
$21.3M795%N/A
#5
$19.8M79-5%N/A